WASHINGTON--(BUSINESS WIRE)--RxAnte, Inc., a leading solution provider for improving medication use and drug therapy outcomes for health plans and providers, announced today a partnership with Geisinger Health Plan, the Danville, Pennsylvania-based health insurer.
Through this partnership, RxAnte will deliver population-level analytics and member-level decision support to inform Geisinger’s pharmacy quality strategy in 2019. The collaborative program will focus on members’ adherence to important maintenance medications related to diabetes, hypertension, and high cholesterol in order to improve health outcomes, drive CMS quality scores, and help avoid unnecessary medical utilization related to non-adherence.
“At Geisinger Health Plan, we are committed to improving the health and well-being of our members and medication adherence is a key part of that objective,” said Jamie Miller, GHP pharmacy director. “Our collaboration with RxAnte will provide us with valuable information to ensure that our members get the most out of their prescription medications, so they can have the best quality of life.”
“We recognize that innovation is a core pillar of Geisinger’s mission, and we’re excited to partner with them as they invest in new ways to give their Medicare members the support they need with their medications,” said Josh Benner, President and CEO of RxAnte. “We look forward to deploying our experienced team and innovative solutions to make an impact on clinical quality measures and drug therapy outcomes together.”
About Geisinger Health Plan
Geisinger Health Plan, begun in 1985, is headquartered in Danville, Pennsylvania. The plan serves nearly 600,000 members in Pennsylvania. Coverage is available for businesses of all sizes, individuals and families, Medicare beneficiaries, Children’s Health Insurance Program and Medical Assistance recipients. For more information, please visit GeisingerHealthPlan.com.
About RxAnte, Inc.
RxAnte, Inc. is dedicated to getting more from medicines. A trusted provider of advanced analytics and targeted clinical programs for health plans and servicing more than 8 million lives, The RxAnte® systems, which are HITRUST and SOC 2-certified, identify members at risk for drug therapy problems and support delivery of appropriate clinical interventions. Since 2011, this proven approach has enabled clients to improve CMS Star Ratings, HEDIS quality measures, and reduce total cost of care. Visit RxAnte.com for more information.